NO180269C - Analogifremgangsmåte for fremstilling av terapeutisk akive aminoketonderivater - Google Patents
Analogifremgangsmåte for fremstilling av terapeutisk akive aminoketonderivaterInfo
- Publication number
- NO180269C NO180269C NO903430A NO903430A NO180269C NO 180269 C NO180269 C NO 180269C NO 903430 A NO903430 A NO 903430A NO 903430 A NO903430 A NO 903430A NO 180269 C NO180269 C NO 180269C
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- therapeutically active
- analogous process
- aminoketone derivatives
- active aminoketone
- Prior art date
Links
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical class NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 title abstract 2
- -1 Aminoketone derivative compounds Chemical class 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 239000003158 myorelaxant agent Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP20141089 | 1989-08-04 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO903430D0 NO903430D0 (no) | 1990-08-03 |
| NO903430L NO903430L (no) | 1991-02-05 |
| NO180269B NO180269B (no) | 1996-12-09 |
| NO180269C true NO180269C (no) | 1997-03-19 |
Family
ID=16440623
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO903430A NO180269C (no) | 1989-08-04 | 1990-08-03 | Analogifremgangsmåte for fremstilling av terapeutisk akive aminoketonderivater |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0414391B1 (de) |
| JP (1) | JPH0625178B2 (de) |
| KR (1) | KR920009062B1 (de) |
| CN (1) | CN1040105C (de) |
| AT (1) | ATE119890T1 (de) |
| CA (1) | CA2022462A1 (de) |
| DE (1) | DE69017794T2 (de) |
| DK (1) | DK0414391T3 (de) |
| FI (1) | FI96856C (de) |
| NO (1) | NO180269C (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5338857A (en) * | 1989-08-04 | 1994-08-16 | Mitsui Toatsu Chemicals Incorporated | Aminoketone derivatives of 1,2-oxazole and use thereof |
| US5194606A (en) * | 1990-02-08 | 1993-03-16 | Mitsui Toatsu Chemicals, Incorporated | Preparation process of aminoketones |
| US5055585A (en) * | 1990-02-08 | 1991-10-08 | Mitsui Toatsu Chemicals, Incorporated | Preparation process of aminoketones |
| JP3164631B2 (ja) * | 1991-02-26 | 2001-05-08 | 三井化学株式会社 | 光学活性アミノケトン誘導体及びその製造法 |
| WO1996010567A1 (en) * | 1994-09-30 | 1996-04-11 | Maruho Co., Ltd. | Aminoketone derivative, physiologically acceptable salt thereof, and use of the same |
| US6214994B1 (en) | 1997-04-21 | 2001-04-10 | Molecular Geriatrics Corporation | Certain substituted 1-aryl-3-piperazin-1′-yl propanones |
| US5693804A (en) * | 1994-11-17 | 1997-12-02 | Molecular Geriatrics Corporation | Substituted 1-aryl-3-piperazin-1'-yl propanones |
| DE10240026A1 (de) * | 2002-08-27 | 2004-03-11 | Merck Patent Gmbh | Verfahren zur Herstellung von Monoalkylaminoketonen |
| JP3789465B1 (ja) | 2005-04-28 | 2006-06-21 | 学校法人立教学院 | イソオキサゾール誘導体又はジヒドロイソオキサゾール誘導体の製造方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE307581B (de) * | 1963-07-31 | 1969-01-13 | Shionogi & Co | |
| JPS5862169A (ja) * | 1981-10-09 | 1983-04-13 | Nippon Kayaku Co Ltd | 新規な５−アミノイソオキサゾ−ル誘導体 |
| JPS58201770A (ja) * | 1982-05-18 | 1983-11-24 | Dainippon Pharmaceut Co Ltd | α−置換−１，２−ベンズイソキサゾ−ル−３−酢酸エステル類並びにその酸付加塩類及び第４級アンモニウム塩類 |
| AU4261285A (en) * | 1984-06-01 | 1985-12-05 | Tokyo Tanabe Company Limited | 1-propanone derivatives |
| JPH0637389B2 (ja) * | 1986-12-26 | 1994-05-18 | 北陸製薬株式会社 | 頻尿治療剤 |
| US4980365A (en) * | 1987-07-13 | 1990-12-25 | Hoechst-Roussel Pharmaceuticals Inc. | N-substituted-5,6-dimethoxy-1,2-benzisoxazole-3-propanamine and related compounds as analgesic and hypotensive agents |
| IE62276B1 (en) * | 1988-03-30 | 1995-01-25 | Sankyo Co | "New isoxazole derivatives for use as cerebro-active drugs and central muscle relaxants" |
-
1990
- 1990-08-01 DE DE69017794T patent/DE69017794T2/de not_active Expired - Fee Related
- 1990-08-01 JP JP2202528A patent/JPH0625178B2/ja not_active Expired - Lifetime
- 1990-08-01 AT AT90308475T patent/ATE119890T1/de not_active IP Right Cessation
- 1990-08-01 FI FI903833A patent/FI96856C/fi not_active IP Right Cessation
- 1990-08-01 EP EP90308475A patent/EP0414391B1/de not_active Expired - Lifetime
- 1990-08-01 CA CA002022462A patent/CA2022462A1/en not_active Abandoned
- 1990-08-01 DK DK90308475.4T patent/DK0414391T3/da active
- 1990-08-03 NO NO903430A patent/NO180269C/no unknown
- 1990-08-04 CN CN90107939A patent/CN1040105C/zh not_active Expired - Fee Related
- 1990-08-04 KR KR1019900011987A patent/KR920009062B1/ko not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| NO903430D0 (no) | 1990-08-03 |
| DE69017794T2 (de) | 1995-08-03 |
| DE69017794D1 (de) | 1995-04-20 |
| FI96856B (fi) | 1996-05-31 |
| AU5998790A (en) | 1991-02-07 |
| CN1040105C (zh) | 1998-10-07 |
| FI903833A0 (fi) | 1990-08-01 |
| EP0414391B1 (de) | 1995-03-15 |
| EP0414391A3 (en) | 1991-07-17 |
| JPH0625178B2 (ja) | 1994-04-06 |
| ATE119890T1 (de) | 1995-04-15 |
| FI96856C (fi) | 1996-09-10 |
| KR920009062B1 (ko) | 1992-10-13 |
| NO180269B (no) | 1996-12-09 |
| JPH03157375A (ja) | 1991-07-05 |
| EP0414391A2 (de) | 1991-02-27 |
| CA2022462A1 (en) | 1991-02-05 |
| DK0414391T3 (da) | 1995-04-03 |
| KR910004609A (ko) | 1991-03-29 |
| AU615621B2 (en) | 1991-10-03 |
| NO903430L (no) | 1991-02-05 |
| CN1049660A (zh) | 1991-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI872864A0 (fi) | Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi | |
| FI881103A0 (fi) | Menetelmä antidiabeettisena aineena käytettävien bensoksatsolijohdannaisten valmistamiseksi | |
| FI893750A0 (fi) | Menetelmä valmistaa terapeuttisesti aktiivista makrosyklistä johdannaista | |
| PT87552A (pt) | Process for the preparation of novel tetrazole intermediates toantihypertensive compounds | |
| NO176356C (no) | Analogifremgangsmåte for fremstilling av nye terapeutisk aktive pyrazolopyridinforbindelser | |
| NO180719C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive A-nor-steroid-3-carboxylsyrederivater | |
| FI894477A7 (fi) | Menetelmä terapeuttisesti aktiivisten 7-substituoitujen 3,5-dihydroksihept-6-yynihappojen ja niiden johdannaisten valmistamiseksi ja välituotteina käyttökelpoiset yhdisteet | |
| NO177387C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive imidazo-kondenserte, 6-leddede, heterocykliske forbindelser | |
| NO890259D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider. | |
| NO892058L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive benzamider. | |
| NO180269C (no) | Analogifremgangsmåte for fremstilling av terapeutisk akive aminoketonderivater | |
| ATE92036T1 (de) | Kardiovaskulaer aktive verbindungen. | |
| PT84716A (en) | Process for the preparation of insecticidal compositions containing six-membered heterocyclic derivatives of n:-substituted-n,n:-diacylhydrazines | |
| PT84718A (en) | Process for the preparation of insecticidal compositions containing five-membered heterocyclic derivatives of n:-substituted-n,n:-diacylhydrazines | |
| KR880007070A (ko) | 백내장 치료용 약학 조성물 | |
| NO167978C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-benzotiazoler. | |
| NO174962C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 2,5,6,7-tetranor-4,8-inter-m-fenylen PGI2-derivater | |
| ATE118209T1 (de) | Pyridin-3-percarboxylsäure monopersulfat. | |
| FI103885B1 (fi) | Menetelmä terapeuttisesti aktiivisten 1-bentsyyli-4-fenyylipiperatsiinijohdannaisten valmistamiseksi ja välituotteina käyttökelpoisia yhdisteitä | |
| PT84635A (en) | Process for the preparation of stable injectable compositions containing 4-amino-5-chloro-n-]2-(diethylamino) ethyl"-2-](substituted) alkoxy" benzamide antiemetic agents | |
| PT73948B (en) | Process for the preparation of biologically active heterobicyclic hydroximidates and thiolhydroximidates and carbamate ester derivatives thereof | |
| IT1224404B (it) | Composti attivi sul sistema cardiovascolare | |
| NO164651C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aminofenol-derivater. | |
| NO175099C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 1,3,5-tritianderivater | |
| FR2395273A1 (fr) | Derives de 7b-((2-amino-1,2-dioxoethyl)amino) acylcephalosporine et leur utilisation comme medicaments |